Caricamento...
FGF23 from bench to bedside
There is a strong association between elevated circulating fibroblast growth factor-23 (FGF23) levels and adverse outcomes in patients with chronic kidney disease (CKD) of all stages. Initially discovered as a regulator of phosphate and vitamin D homeostasis, FGF23 has now been implicated in several...
Salvato in:
| Pubblicato in: | Am J Physiol Renal Physiol |
|---|---|
| Autori principali: | , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
American Physiological Society
2016
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6425620/ https://ncbi.nlm.nih.gov/pubmed/26864938 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajprenal.00606.2015 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|